Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Twist Bioscience Corporation logo

NASDAQ · TWST

Twist Bioscience Corporation

Healthcare · Medical - Diagnostics & Research

$152.78

Down-$20.67 (-11.92%)

Updated Nov 1, 2026, 11:49 AM

SID Score

5.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.92B
P/E ratio
-25.04
Dividend yield
0.00%
52-week range
$41.52 – $219.71
Volume
3.4M
Avg. volume
1.74M

Price performance · TWST

TWST price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

TWST closed at $152.78 after 20 trading sessions, down 25.47% for the selected period.

Last close
$152.78
Period change
-25.47%
Period low
$132.75
Period high
$205.00
Daily close
View OHLC price history
TWST OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$162.94$167.27$148.00$152.783.4M
Oct 29, 2026$170.43$177.99$169.07$173.451.78M
Oct 28, 2026$160.44$178.53$159.00$173.453.49M
Oct 27, 2026$145.74$162.61$143.70$159.851.76M
Oct 26, 2026$139.45$147.6228$136.19$145.251.38M
Oct 23, 2026$132.95$140.74$131.23$139.921.86M
Oct 22, 2026$143.50$150.14$131.85$135.472.69M
Oct 21, 2026$139.335$153.80$138.25$149.132.64M
Oct 20, 2026$139.77$148.83$134.94$142.702.02M
Oct 19, 2026$136.99$141.80$133.72$139.771.59M
Oct 16, 2026$143.88$145.05$130.9825$132.752.83M
Oct 15, 2026$138.09$148.32$130.6798$144.493.54M
Oct 14, 2026$146.69$156.00$144.79$148.162.12M
Oct 13, 2026$149.00$154.23$146.00$151.331.53M
Oct 12, 2026$159.78$161.80$147.5522$151.862.65M
Oct 9, 2026$152.69$168.93$152.1375$159.783.54M
Oct 8, 2026$148.002$152.59$144.60$152.054.37M
Oct 7, 2026$158.26$167.44$152.50$155.655.9M
Oct 6, 2026$209.55$219.7126$164.49$166.978.56M
Oct 5, 2026$193.46$207.90$189.25$205.003.21M

Latest TWST news

The latest Smart Investors Daily articles mentioning TWST.

Stock researchCompany · Overview

TWST research

Overview

Company profile and research snapshot.

Company profile

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$42.33
Implied upside
—
Analysts
—
TWST recent ratings
DateFirmRatingTarget
Oct 13, 2026TD CowenBuy—
Oct 12, 2026Canaccord GenuityBuy—
Oct 8, 2026JefferiesHold—
Oct 7, 2026BarclaysOverweight—
Oct 1, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026

SOUTH SAN FRANCISCO, Calif., October 26, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that it will issue its financial results for the fiscal 2026 fourth quarter and full year ended September 30, 2026, before the opening of the market on November 12, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update

Yahoo · Oct 23, 2026

BWX Technologies, Inc. (BWXT) Faces Share-Price Pressure Despite Strong Backlog and Higher Guidance

Polen Capital, an investment management company, released its “Polen 5Perspectives Small-Mid Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here. The fund struggled during the third quarter of 2026 as volatility in AI-related equities, shifting investor expectations, and renewed concerns about inflation and interest rates weighed on small- and […]

Yahoo · Oct 23, 2026

TeraWulf Inc. (WULF) Shares Retreat as Investors Reassess AI Data Center Growth Prospects

Polen Capital, an investment management company, released its “Polen 5Perspectives Small-Mid Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here. The fund struggled during the third quarter of 2026 as volatility in AI-related equities, shifting investor expectations, and renewed concerns about inflation and interest rates weighed on small- and […]

Yahoo · Oct 23, 2026

nLIGHT, Inc. (LASR) Faces Pressure After Third-Quarter Revenue Guidance Falls Short

Polen Capital, an investment management company, released its “Polen 5Perspectives Small-Mid Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here. The fund struggled during the third quarter of 2026 as volatility in AI-related equities, shifting investor expectations, and renewed concerns about inflation and interest rates weighed on small- and […]

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By